Oaktree Acquisition Corp. III Life Sciences (OACCW) P/E Ratio History
Fairly ValuedTrading at 3.1x, near 5Y avg of 3.2x · 50th percentile · In line with own history · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of July 8, 2026, Oaktree Acquisition Corp. III Life Sciences (OACCW) trades at a price-to-earnings ratio of 3.1x, with a stock price of $0.93 and trailing twelve-month earnings per share of $0.34.
The current P/E is roughly in line with its 5-year average of 3.2x. Over the past five years, OACCW's P/E has ranged from a low of 2.8x to a high of 3.6x, placing the current valuation at the 50th percentile of its historical range.
Compared to the Financial Services sector median P/E of 14.3x, OACCW trades at a 78% discount to its sector peers. The sector includes 800 companies with P/E ratios ranging from 0.0x to 157.0x.
Relative to the broader market, OACCW trades at a notable discount to the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OACCW DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OACCW Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
OACCW P/E vs Peers
Healthcare and life sciences SPACs peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $151M | 47.5 | - | -76% | |
| $95B | 31.2 | 1.49 | +7% | |
| $85B | 40.7 | - | -29% | |
| $69B | 16.4Lowest | 0.22Best | -1% | |
| $16B | 20.2 | 1.15 | -21% | |
| $40B | 61.6 | 3.49 | -5% | |
| $16B | 35.1 | - | +1779%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
OACCW Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $0.75 | $0.27 | 2.8x | -13% |
| FY2025 Q3 | - | $0.75 | $0.21 | 3.6x | +13% |
Average P/E for displayed period: 3.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OACCW — Frequently Asked Questions
Quick answers to the most common questions about buying OACCW stock.
What is OACCW's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences (OACCW) trailing twelve-month P/E ratio is 3.1x, based on TTM diluted EPS of $0.34. The 5-year average P/E is 3.2x and the historical range spans 2.8x to 3.6x.
Is OACCW stock overvalued or undervalued?
OACCW trades at 3.1x P/E, near its 5-year average of 3.2x. The 50th percentile ranking within the 2.8x–3.6x historical range places valuation within normal bounds.
Is OACCW stock expensive?
OACCW is fairly valued relative to its own history. The current P/E of 3.1x is near the 5-year average of 3.2x (50th percentile of historical range).
What is OACCW's historical P/E range?
Over the past 5 years, OACCW's P/E ratio has ranged from 2.8x to 3.6x, with a median of 3.6x and an average of 3.2x. The current P/E of 3.1x places the stock at the 50th percentile of this range. Full historical data spans 2025–2026.
How does OACCW's P/E compare to the S&P 500?
OACCW trades at 3.1x P/E versus the S&P 500 median of 25.9x. The 88% discount to the market suggests lower growth expectations or perceived higher risk.
How does OACCW's valuation compare to Financial Services peers?
Oaktree Acquisition Corp. III Life Sciences P/E of 3.1x compares to the Financial Services sector median of 14.3x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is OACCW's PEG ratio?
OACCW PEG ratio is N/A, based on a P/E of 3.1x and EPS growth of 453.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is OACCW's earnings yield?
OACCW earnings yield is 32.38%, the inverse of its 3.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.